We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGM
326
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$6.45M 0.05%
221,634
MRSH
327
Marsh
MRSH
$94.3B
$6.42M 0.05%
57,104
ODFL icon
328
Old Dominion Freight Line
ODFL
$46.3B
$6.41M 0.05%
68,398
DGX icon
329
Quest Diagnostics
DGX
$26B
$6.41M 0.05%
56,010
PBA icon
330
Pembina Pipeline
PBA
$29.3B
$6.4M 0.05%
281,978
LRCX icon
331
Lam Research
LRCX
$316B
$6.29M 0.05%
138,740
DHI icon
332
D.R. Horton
DHI
$41.2B
$6.28M 0.05%
94,901
PLNT icon
333
Planet Fitness
PLNT
$4.45B
$6.25M 0.05%
83,743
RDUS
334
DELISTED
Radius Health, Inc.
RDUS
$6.05M 0.05%
352,567
SIVB
335
DELISTED
SVB Financial Group
SIVB
$6.04M 0.05%
16,224
AVTR icon
336
Avantor
AVTR
$9.73B
$5.97M 0.05%
220,878
KR icon
337
Kroger
KR
$36.7B
$5.97M 0.05%
195,564
-1
-0% -$34
REPL icon
338
Replimune Group
REPL
$455M
$5.94M 0.05%
162,160
+6
+0% +$225
AZO icon
339
AutoZone
AZO
$51.3B
$5.93M 0.05%
5,207
MCK icon
340
McKesson
MCK
$104B
$5.89M 0.05%
35,275
VIR icon
341
Vir Biotechnology
VIR
$1.46B
$5.82M 0.05%
226,238
CLDX icon
342
Celldex Therapeutics
CLDX
$2.94B
$5.79M 0.05%
344,139
MSI icon
343
Motorola Solutions
MSI
$72.1B
$5.66M 0.05%
34,658
TSCO icon
344
Tractor Supply
TSCO
$16.3B
$5.64M 0.05%
208,710
-50
-0% -$1.59K
ZTS icon
345
Zoetis
ZTS
$32.7B
$5.62M 0.05%
35,379
EXPD icon
346
Expeditors International
EXPD
$22.3B
$5.56M 0.05%
60,808
+15
+0% +$1.44K
MKC icon
347
McCormick & Company Non-Voting
MKC
$14B
$5.52M 0.05%
60,136
SCCO icon
348
Southern Copper
SCCO
$138B
$5.5M 0.05%
94,927
PVLA
349
Palvella Therapeutics
PVLA
$2.05B
$5.46M 0.05%
28,409
OC icon
350
Owens Corning
OC
$11B
$5.44M 0.05%
74,782
+18
+0% +$1.51K

Similar funds

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.